Connect with us

AI Research

2 Top Artificial Intelligence (AI) Stocks That Pay Decent Dividends and Have Good Dividend-Paying Histories

Published

on


Key Points

  • Shares of Taiwan Semiconductor Manufacturing Co. (TSMC) and IBM have crushed the S&P 500’s returns over the last one year, three years, and five years.

  • And TSMC stock has absolutely pulverized the broader market over the 10-year period.

  • Shares of TSMC and IBM are currently yielding 1.26% and 2.31%, respectively.

Artificial intelligence (AI) is the biggest secular growth trend today. The global AI market will soar from $189 billion in 2023 to $4.8 trillion by 2033 — a 25-fold increase in a decade — according to a recent projection by the United Nations Conference on Trade and Development.

As with technology stocks in general, the vast majority of stocks that could be considered AI stocks either do not pay dividends or pay very small ones.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

While they are relatively rare, there are some top-performing AI stocks that pay decent dividends and have a good dividend payment history. These include the world’s largest semiconductor (or “chip”) foundry Taiwan Semiconductor Manufacturing Corp., or TSMC (NYSE: TSM), and International Business Machines, or IBM (NYSE: IBM), one of the world’s oldest large tech companies.

So, folks who like dividend-paying stocks and want to invest in AI — forgive the cliché — can have their cake and eat it too.

Image source: Getty Images.

2 Top AI stocks that pay decent dividends

Company

Market Cap

Dividend Yield

Forward P/E Ratio

Wall Street’s Projected Annualized EPS Growth Over Next 5 Years

5-Year Return

Taiwan Semiconductor Manufacturing

$963 billion

1.26% 24.2 22.7% 296%
IBM $270 billion 2.31% 26.7 6.3% 223%

S&P 500

N/A

1.24% N/A

N/A

112%

Data sources: Finviz.com and Yahoo! Finance. P/E = price to earnings. EPS = earnings per share. Data as of July 8, 2025.

TSMC: The world’s largest chip foundry

Taiwan Semiconductor Manufacturing produces chips for companies that contract out all or some of the manufacturing of chips that they design. As the world’s largest chip foundry, TSMC is the dominant company in the production of advanced AI chips, so it’s been significantly benefiting from the growth of the AI market and should continue to benefit.

TSMC’s customers includes most of the big names in chip companies — such as Nvidia, Broadcom, and Arm Holdings. It also produces chips for big tech companies that have designed their own chips, including Apple, which is widely considered TSMC’s largest customer, followed by Nvidia.

The company is off to a great start in 2025. In the first quarter, its revenue jumped 35% year over year to $25.5 billion, driven by continued strong AI-related demand. Better yet, its EPS surged 54% to $2.12. Its EPS growing faster than its revenue reflects its expanding profit margin.

On the Q1 earnings call, management reaffirmed its 2025 guidance that its revenue from AI accelerators will double year over year.

TSMC started paying cash dividends in 2004 and has never halted or reduced its dividend per share.

TSMC stock is trading at 24.2 times its forward projected EPS, which is reasonable for a stock of a company that Wall Street expects will grow EPS at an average annual rate of nearly 23% over the next five years.

IBM: Successfully transitioning to AI and other high-growth markets

IBM has been in a years-long transitioning mode, divesting of legacy businesses and investing in growth markets, notably cloud computing and AI. This transitioning resulted in its revenue declining, which in turn caused its profits and cash flows to also decrease. But Big Blue is back in growth mode.

In 2024, IBM’s revenue increased 3% in constant currency to $62.8 billion, driven by a 9% rise in software revenue, offset by declines of 1% and 3% in its consulting and infrastructure segments, respectively. Adjusted earnings per share (EPS) from continuing operations was up 7% year over year. Free cash flow (FCF) rose 13% year over year to $12.7 billion.

IBM’s generative AI book of business ended the year at $5 billion inception to date. (Generative AI enables users to quickly generate new content based on a variety of inputs. It’s the type of AI that’s largely powering the AI boom.)

The AI business is growing fast, increasing $2 billion from the third to the fourth quarter 2024. Moreover, it tacked on another $1 billion-plus in the first quarter of 2025 to bring its total to more than $6 billion. About one-fifth of this business comes from software and four-fifths from consulting, CEO Arvind Krishna said on the Q1 earnings call.

The company expects revenue growth to accelerate in 2025. For the year, it guided for annual revenue growth of at least 5% in constant currency and FCF of about $13.5 billion, or over 6% growth year over year.

IBM has a great dividend history. It’s increased its quarterly cash dividend for 30 consecutive years.

IBM stock is trading at 26.7 times forward projected EPS. This might seem quite pricey for shares of a company that Wall Street expects will grow EPS at an average annual pace of 6.3% over the next five years. However, investors can expect to pay a premium for stocks of companies that have great track records of raising their dividends.

Moreover, the stock might turn out to be less pricey than it currently seems. IBM has solidly beat the analyst consensus estimate for earnings in the last four quarters, with two of the beats being quite large. Given how fast the company’s AI business is growing, it could continue to solidly surpass earnings estimates.

Mark your calendars

TSMC is slated to release its Q2 2025 results before the market open on Thursday, July 17.

IBM is scheduled to release its Q2 results after the market close on Wednesday, July 23.

Should you invest $1,000 in Taiwan Semiconductor Manufacturing right now?

Before you buy stock in Taiwan Semiconductor Manufacturing, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Taiwan Semiconductor Manufacturing wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider whenNetflixmade this list on December 17, 2004… if you invested $1,000 at the time of our recommendation,you’d have $687,764!* Or when Nvidiamade this list on April 15, 2005… if you invested $1,000 at the time of our recommendation,you’d have $980,723!*

Now, it’s worth notingStock Advisor’s total average return is1,048% — a market-crushing outperformance compared to179%for the S&P 500. Don’t miss out on the latest top 10 list, available when you joinStock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 7, 2025

Beth McKenna has positions in Nvidia. The Motley Fool has positions in and recommends Apple, International Business Machines, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.



Source link

AI Research

Artificial Intelligence (AI) in Healthcare Market worth

Published

on


The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US)

Browse 902 market data Tables and 67 Figures spread through 711 Pages and in-depth TOC on “Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region – Global Forecast to 2030
The global Artificial Intelligence (AI) in Healthcare Market [https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket], valued at US$14.92 billion in 2024, is forecasted to grow at a robust CAGR of 38.6%, reaching US$21.66 billion in 2025 and an impressive US$110.61billion by 2030. The growing incidence of chronic diseases, linked with an increasing geriatric population, puts substantial financial pressure on healthcare providers. There is a rising need for the early detection of conditions such as dementia and cardiovascular disorders. This can be done by analysing imaging data to recognize patterns, which helps create personalized treatment plans.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

Browse in-depth TOC on “Artificial Intelligence (AI) in Healthcare Market”

882 – Tables

61 – Figures

738 – Pages

By tools, the Artificial Intelligence (AI) in healthcare market for machine learning has been bifurcated into deep learning, supervised learning, reinforcement learning, unsupervised learning, and other machine learning technologies. The deep learning segment accounted for the largest share of the Artificial Intelligence (AI) in healthcare market in 2024. The capability to process vast amounts of unstructured medical data, such as electronic health records (HER), imaging, and genomics, allows accurate disease diagnosis and prediction. The integration of deep learning into healthcare is significantly boosting the AI in healthcare market, leading to substantial investments in diagnostic tools and predictive analytics. As computational power and data availability continue to increase, deep learning is set to unlock further advancements, solidifying its position as a key enabler of next-generation healthcare technologies.

By end user, the AI in healthcare market is segmented into healthcare providers, healthcare payers, patients, and other end users. In 2024, healthcare providers accounted for the largest share of the AI in healthcare market. The large share of this end-user segment can be attributed to the increasing budgets of hospitals to improve the quality of care provided and reduce the cost of care.

By geography, the Artificial Intelligence (AI) in healthcare market is segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to see a substantial growth rate during the forecast period. The Asia Pacific (APAC) region is experiencing substantial growth in adopting AI technologies within the healthcare sector, driven by a combination of demographic shifts, technological advancements, and increased investments in innovation. The rising elderly population in the region is a key factor, with the proportion of individuals aged 65 years and above increasing significantly. The demand for advanced healthcare solutions has surged as the aging population faces chronic and age-related conditions, necessitating efficient diagnostic, monitoring, and treatment tools. AI technologies are being integrated into various healthcare applications, including predictive analytics, telemedicine, medical imaging, and patient management systems. These innovations aim to address gaps in healthcare access, improve diagnostic accuracy, and streamline operations across the region.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is a leading player in the AI in the healthcare market. The company utilizes AI to deliver innovative tools across various areas, including diagnostic imaging, patient monitoring, and precision medicine. Its advanced AI-driven platforms, such as the Philips HealthSuite, facilitate the integration and analysis of extensive clinical data, which supports personalized treatment plans and improves patient outcomes. Philips focuses on organic and inorganic growth strategies to expand its market presence.

Strategic partnerships in high-potential markets and collaborations have been the key growth strategies of the company over the years. For example, in February 2025, Philips partnered with Medtronic to educate and train cardiologists and radiologists in India on advanced imaging techniques for structural heart diseases. This partnership aims to upskill 300+ clinicians in multi-modality imaging such as echocardiography (echo) and Magnetic Resonance Imaging (MRI), especially for End-Stage Renal Disease (ESRD) patients. In November 2023, Philips and NYU Langone Health partnered to focus on patient safety and outcomes. This partnership integrated innovative health technologies, including digital pathology, clinical informatics, and AI-enabled diagnostics, enabling real-time collaboration among clinicians. The company also focuses on winning contracts across several companies in the healthcare space. This helps the company expand its footprint. For instance, in September 2022, Philips and Mandaya Royal Hospital Puri (MRHP) in Jakarta underwent a digital transformation in a strategic partnership, enhancing patient-centered care and healthcare services.

Microsoft Corporation (US):

Microsoft Corporation is one of the leading providers of software & tools that include advanced AI capabilities in healthcare to improve patient outcomes, streamline operations, and drive innovation. Its Azure-based AI solutions support distinct applications such as medical imaging, genomics, and precision medicine. The company also provides healthcare-specific AI models through its Azure AI Model Catalog, which is constructed to support hospitals and research institutions in building and deploying tailored AI solutions proficiently. Moreover, the integration of Nuance’s AI-powered clinical and diagnostic tools encourages its capacity to support healthcare providers in decision-making and care delivery. The company continuously brings AI capabilities to the platforms in large-scale customer models. For instance, in March 2025, the company launched Microsoft Dragon Copilot, the first unified voice AI assistant in the healthcare industry that enables clinicians to streamline clinical documentation, surface information, and automate tasks.

Microsoft Corporation has invested significantly in R&D, which has improved its product portfolio and position in the AI market. Machine Learning (ML), deep learning, Natural Language Processing (NLP), and speech processing are the key focus areas of the company in the AI in healthcare market. The company continuously invests in a series of services and computational biology projects, including research support tools for next-generation precision healthcare, genomics, immunomics, CRISPR, and cellular and molecular biologics. It has a strong global presence, with key operations supported through its Azure cloud infrastructure across regions like North America, Europe, Asia-Pacific, and the Middle East.

For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=54679303&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=artificialintelligenceinhealthcaremarket]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=artificial-intelligence-ai-in-healthcare-market-worth-11061-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com

This release was published on openPR.



Source link

Continue Reading

AI Research

LLM-Optimized Research Paper Formats: AI-Driven Research App Opportunities Explored | AI News Detail

Published

on


The concept of shifting attention from human-centric to Large Language Model (LLM) attention, as highlighted by Andrej Karpathy in a tweet on July 10, 2025, opens a fascinating discussion about the future of research and information consumption in the AI era. Karpathy, a prominent figure in AI and former director of AI at Tesla, posits that 99% of attention may soon be directed toward LLMs rather than humans, raising the question: what does a research paper look like when designed for an LLM instead of a human reader? This idea challenges traditional formats like PDFs, which are static and optimized for human cognition with visual layouts and narrative structures. Instead, LLMs require data-rich, structured, and machine-readable formats that prioritize efficiency, context, and interoperability. This shift could revolutionize industries such as academia, tech development, and business intelligence by enabling faster knowledge synthesis and application. As of 2025, with AI adoption accelerating—Gartner reported in early 2025 that 80% of enterprises are piloting or deploying generative AI tools—the need for LLM-optimized content is becoming critical. This trend reflects a broader transformation in how information is created, consumed, and monetized in an AI-driven world, with significant implications for content creators and tech innovators.

From a business perspective, the idea of designing research for LLMs presents immense market opportunities. Companies that develop platforms or apps to create, curate, and deliver LLM-friendly research content could tap into a multi-billion-dollar market. According to a 2025 report by McKinsey, the generative AI market is projected to grow to $1.3 trillion by 2032, with content generation and data processing as key drivers. A ‘research app’ for LLMs, as Karpathy suggests, could serve industries like pharmaceuticals, where AI models analyze vast datasets for drug discovery, or finance, where real-time market insights are critical. Monetization strategies could include subscription models for premium datasets, API access for developers, or enterprise solutions for tailored LLM training data. However, challenges remain, such as ensuring data privacy and preventing bias in LLM outputs—issues that have plagued AI systems, as noted in a 2025 study by the MIT Sloan School of Management, which found that 60% of AI deployments faced ethical concerns. Businesses must also navigate a competitive landscape with players like Google, OpenAI, and Anthropic already dominating LLM development, requiring niche specialization to stand out.

On the technical side, designing research for LLMs involves moving beyond PDFs to formats like JSON, XML, or custom data schemas that encode information hierarchically for machine parsing. Unlike human readers, LLMs thrive on structured datasets with metadata, embeddings, and cross-references that enable rapid context retrieval and reasoning. Implementation challenges include standardizing formats across industries and ensuring compatibility with diverse LLM architectures—a hurdle given that, as of mid-2025, over 200 distinct LLM frameworks exist, per a report from the AI Index by Stanford University. Solutions could involve open-source protocols or industry consortia to define standards, much like the web evolved with HTML. Looking to the future, LLM-optimized research could lead to autonomous AI agents conducting real-time literature reviews or hypothesis generation by 2030, as predicted by a 2025 forecast from Deloitte. Regulatory considerations are also critical, with the EU AI Act of 2025 mandating transparency in AI data usage, which could impact how research content is structured. Ethically, ensuring that LLMs do not misinterpret or propagate flawed data remains a priority, requiring robust validation mechanisms. The potential for such innovation is vast, offering a glimpse into a future where knowledge creation is as much for machines as for humans, reshaping industries and workflows profoundly.



Source link

Continue Reading

AI Research

Digital Agency Fuel Online Launches AI SEO Research Division,

Published

on


Boston, MA – As Google continues to reshape the digital landscape with its Search Generative Experience (SGE) and AI-powered search results, Fuel Online [https://fuelonline.com/] is blazing a trail as the nation’s leading agency in AI SEO [https://fuelonline.com/]and SGE optimization [https://fuelonline.com/].

Recognizing the urgent need for businesses to adapt to AI-first search engines, Fuel Online has launched a dedicated AI SEO Research & Development Division focused exclusively on decoding how AI models like Google SGE read, rank, and render web content. The division’s mission: to test, reverse-engineer, and deploy cutting-edge strategies that future-proof clients’ visibility in an era of AI-generated search answers.

“AI is not the future of SEO – it’s the present . If your content doesn’t rank in SGE, it may never be seen. That’s why we’re investing heavily in understanding and optimizing for how large language models surface content,” said Scott Levy, CEO of Fuel Online Digital Marketing Agency [https://fuelonline.com/].

Fuel Online’s Digital Marketing team is already helping Fortune 500 brands, high-growth startups, and ecommerce leaders gain traction in AI-powered results using proprietary tactics including:

* NLP entity linking & semantic schema
* SGE-optimized content blocks & voice search targeting
* AI-readiness audits tailored for Google’s evolving ranking models

As detailed in their comprehensive Google SGE & AI Optimization Guide [https://fuelonline.com/insights/google-sge-and-ai-optimization-guide-how-to-optimize/], Fuel Online offers strategic insight into aligning websites with Google’s new generative layer. The agency also provides live testing environments, allowing clients to see firsthand how AI engines interpret their content. Why This Matters: According to industry data, click-through rates have dropped by up to 60% on some keywords since the rollout of SGE, as users get direct AI-generated answers instead of traditional blue links. Fuel Online’s AI SEO division helps clients reclaim that lost visibility and win placement inside AI search results. With over two decades of award-winning digital strategy under its belt and a reputation as one of the top digital marketing agencies in the U.S., Fuel Online is once again setting the standard – this time for the AI optimization era.

Media Contact:

Fuel Online

Boston, MA

(888)-475-2552

https://FuelOnline.com

Media Contact
Company Name: Fuel Online
Contact Person: Media Relation Management
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=digital-agency-fuel-online-launches-ai-seo-research-division-cementing-its-position-at-the-forefront-of-sge-optimization]
Phone: (888)-475-2552
City: Boston
State: MA
Country: United States
Website: https://fuelonline.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com

This release was published on openPR.



Source link

Continue Reading

Trending